32925200|t|Clinical Profiles of Arteriolosclerosis and Alzheimer Disease at Mild Cognitive Impairment and Mild Dementia in a National Neuropathology Cohort.
32925200|a|OBJECTIVE: We sought to evaluate early clinical differences between cerebral arteriolosclerosis (pARTE), Alzheimer disease (pAD), and AD with arteriolosclerosis (ADARTE). METHODS: Using National Alzheimer's Coordinating Center neuropathology diagnoses, we defined pARTE (n=21), pAD (n=203), and ADARTE (n=158) groups. We compared demographics, medical history, psychometrics, neuropsychiatric symptoms, and apolipoprotein E (APOE) allele variants across neuropathology groups. Retrospective timepoints were first evaluation with Global Clinical Dementia Rating (CDR) score of 0.5 and 1.0, via the CDR Dementia Staging Instrument, corresponding to mild cognitive impairment (MCI) and mild dementia, respectively. RESULTS: In MCI, clinical differences were minimal but pARTE subjects were older, had later onset cognitive decline, and progressed less severely than pAD. In mild dementia, pAD subjects were younger and had earlier onset of decline. Neuropsychiatric (depression) and psychometric (Logical Memory Delayed Recall, Trails B) differences also emerged between the groups. In MCI, APOE4 associated with worse Logical Memory Delayed Recall in pAD and ADARTE. In mild dementia, APOE4 associated with better animal fluency in pAD, but with better Trails A performance and more neuropsychiatric symptoms (Neuropsychiatric Inventory Questionnaire) in ADARTE. CONCLUSIONS: Differences between pARTE, pAD, and ADARTE emerge at mild dementia rather than MCI. APOE4 has varied cognitive and psychiatric impact dependent on neuropathology group and stage.
32925200	21	39	Arteriolosclerosis	Disease	MESH:D050379
32925200	44	61	Alzheimer Disease	Disease	MESH:D000544
32925200	70	90	Cognitive Impairment	Disease	MESH:D003072
32925200	100	108	Dementia	Disease	MESH:D003704
32925200	214	241	cerebral arteriolosclerosis	Disease	MESH:D050379
32925200	243	248	pARTE	Disease	MESH:D018227
32925200	251	268	Alzheimer disease	Disease	MESH:D000544
32925200	270	273	pAD	Disease	MESH:C567780
32925200	280	306	AD with arteriolosclerosis	Disease	MESH:D050379
32925200	308	314	ADARTE	Disease	MESH:D050379
32925200	341	350	Alzheimer	Disease	MESH:D000544
32925200	410	415	pARTE	Disease	MESH:D018227
32925200	424	427	pAD	Disease	MESH:C567780
32925200	441	447	ADARTE	Disease	MESH:D050379
32925200	522	547	neuropsychiatric symptoms	Disease	MESH:D001523
32925200	553	569	apolipoprotein E	Gene	348
32925200	571	575	APOE	Gene	348
32925200	691	699	Dementia	Disease	MESH:D003704
32925200	747	755	Dementia	Disease	MESH:D003704
32925200	798	818	cognitive impairment	Disease	MESH:D003072
32925200	820	823	MCI	Disease	MESH:D060825
32925200	834	842	dementia	Disease	MESH:D003704
32925200	870	873	MCI	Disease	MESH:D060825
32925200	913	918	pARTE	Disease	MESH:D018227
32925200	956	973	cognitive decline	Disease	MESH:D003072
32925200	1009	1012	pAD	Disease	MESH:C567780
32925200	1022	1030	dementia	Disease	MESH:D003704
32925200	1032	1035	pAD	Disease	MESH:C567780
32925200	1110	1120	depression	Disease	MESH:D003866
32925200	1229	1232	MCI	Disease	MESH:D060825
32925200	1234	1239	APOE4	Gene	348
32925200	1295	1298	pAD	Disease	MESH:C567780
32925200	1303	1309	ADARTE	Disease	MESH:D050379
32925200	1319	1327	dementia	Disease	MESH:D003704
32925200	1329	1334	APOE4	Gene	348
32925200	1376	1379	pAD	Disease	MESH:C567780
32925200	1427	1452	neuropsychiatric symptoms	Disease	MESH:D001523
32925200	1499	1505	ADARTE	Disease	MESH:D050379
32925200	1540	1545	pARTE	Disease	MESH:D018227
32925200	1547	1550	pAD	Disease	MESH:C567780
32925200	1556	1562	ADARTE	Disease	MESH:D050379
32925200	1578	1586	dementia	Disease	MESH:D003704
32925200	1599	1602	MCI	Disease	MESH:D060825
32925200	1604	1609	APOE4	Gene	348
32925200	1635	1646	psychiatric	Disease	MESH:D001523
32925200	Association	MESH:D001523	348
32925200	Association	MESH:C567780	348
32925200	Association	MESH:D050379	348

